Andrew Mok
Stock Analyst at Barclays
(2.56)
# 2,256
Out of 4,863 analysts
183
Total ratings
50%
Success rate
-0.47%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $273 → $268 | $235.39 | +13.85% | 10 | Jun 12, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $351 → $347 | $290.25 | +19.55% | 7 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $362 → $350 | $307.66 | +13.76% | 10 | Jun 2, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $215 | $164.24 | +30.91% | 13 | Jun 2, 2025 | |
| HCA HCA Healthcare | Maintains: Overweight | $366 → $416 | $368.59 | +12.86% | 10 | Jun 2, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $522 → $480 | $376.53 | +27.48% | 8 | Jun 2, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $79 | $67.71 | +16.67% | 9 | Jun 2, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $382 → $385 | $314.44 | +22.44% | 6 | Jun 2, 2025 | |
| CNC Centene | Downgrades: Equal-Weight | $84 → $65 | $54.68 | +18.87% | 8 | Jun 2, 2025 | |
| SGRY Surgery Partners | Maintains: Equal-Weight | $25 → $24 | $23.07 | +4.05% | 2 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $23 → $24 | $22.89 | +4.87% | 8 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $35 → $28 | $21.12 | +32.58% | 13 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $3 | $2.18 | +37.61% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $249 → $257 | $170.36 | +50.86% | 22 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $130 | $120.51 | +7.87% | 16 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $36 | $24.94 | +44.35% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $60 | $57.43 | +4.48% | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $14.50 | -37.93% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $4 | $3.18 | +25.79% | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $164 → $169 | $137.84 | +22.61% | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $114.44 | -27.47% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $9.89 | +21.40% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $97.37 | -2.43% | 7 | Aug 2, 2022 |
Humana
Jun 12, 2025
Maintains: Equal-Weight
Price Target: $273 → $268
Current: $235.39
Upside: +13.85%
Molina Healthcare
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $351 → $347
Current: $290.25
Upside: +19.55%
UnitedHealth Group
Jun 2, 2025
Maintains: Overweight
Price Target: $362 → $350
Current: $307.66
Upside: +13.76%
Tenet Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $171 → $215
Current: $164.24
Upside: +30.91%
HCA Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $366 → $416
Current: $368.59
Upside: +12.86%
Elevance Health
Jun 2, 2025
Maintains: Overweight
Price Target: $522 → $480
Current: $376.53
Upside: +27.48%
CVS Health
Jun 2, 2025
Maintains: Overweight
Price Target: $82 → $79
Current: $67.71
Upside: +16.67%
The Cigna Group
Jun 2, 2025
Maintains: Overweight
Price Target: $382 → $385
Current: $314.44
Upside: +22.44%
Centene
Jun 2, 2025
Downgrades: Equal-Weight
Price Target: $84 → $65
Current: $54.68
Upside: +18.87%
Surgery Partners
May 27, 2025
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $23.07
Upside: +4.05%
May 27, 2025
Maintains: Equal-Weight
Price Target: $23 → $24
Current: $22.89
Upside: +4.87%
May 14, 2025
Maintains: Equal-Weight
Price Target: $35 → $28
Current: $21.12
Upside: +32.58%
May 8, 2025
Maintains: Underweight
Price Target: $2 → $3
Current: $2.18
Upside: +37.61%
Apr 29, 2025
Maintains: Overweight
Price Target: $249 → $257
Current: $170.36
Upside: +50.86%
Apr 28, 2025
Maintains: Buy
Price Target: $117 → $130
Current: $120.51
Upside: +7.87%
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $24.94
Upside: +44.35%
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $57.43
Upside: +4.48%
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $14.50
Upside: -37.93%
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $3.18
Upside: +25.79%
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $137.84
Upside: +22.61%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $114.44
Upside: -27.47%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $9.89
Upside: +21.40%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $97.37
Upside: -2.43%